EuroAsia RND — Research & DevelopmentRNDResearch & Development Enquiry 0

Merestinib

MET/RON/AXL/TIE2/TRKA Inhibitor

CAS
1206799-15-6
Formula
C30H22F2N6O3
Mol. weight
552.54 g/mol
Purity
≥99%

Price on request. CoA, HPLC, NMR and SDS available on request. For Research Use Only. Not for human or veterinary use.

2D structure of Merestinib
Structure from PubChem CID 44603533

Multi-targeted type II kinase inhibitor; potent MET and RON inhibitor; studied in combination with CDK4/6 inhibitors. RON receptor — rare addition to MET inhibitor class

Target class: ALK, ROS1, RET and TRK inhibitors
Research areas: Lung Cancer

Related compounds

SMILESCC1=CC=C(C(=O)N1C2=CC=C(C=C2)F)C(=O)NC3=CC(=C(C=C3)OC4=C(C=C5C(=C4)C=NN5C)C6=CNN=C6)F
InChIKeyQHADVLVFMKEIIP-UHFFFAOYSA-N